Screen Reader Mode Icon

Content

Question Title

* 1. Please enter your name (this is required according to the Medicinal Products Act). 

Question Title

* 2. Any mistakes you noticed (e.g. incorrect or misleading information, spelling)

Question Title

* 3. Any content you missed

Question Title

* 4. Most frequently read / most important content 

Question Title

* 5. Most frequently used (instant button)

Question Title

* 6. Specific content is easy to find. 

Question Title

* 7. The content is clearly structured.

Question Title

* 8. The content is uptodate.

Question Title

* 9. The content is correct.

Question Title

* 10. The content is complete.

Question Title

* 11. The content improves the daily clinical practice.

Question Title

* 12. The chapters Eligibility, Leukapheresis, Bridging and CAR T cell transfusion...

  Strongly agree Agree Neither agree or disagree Disagree Strongly disagree
... are comprehensively presented.
... include new information I did not know about of so far.
... facilitate the steps prior to the application of CARs and BiTEs.

Question Title

* 13. The toxicity chapter ...

  Strongly agree Agree Neither agree or disagree Disagree Strongly disagree
... is comprehensively presented.
... includes new information I did not know about of so far.
... facilitates the toxicity management of CARs and BiTEs.
0 of 38 answered
 

T